Charity Threatens Legal Action Over Two-Year NHS Wait for ADHD and Autism Assessments

Background to the West Yorkshire ICB policy

In early 2024 the West Yorkshire Integrated Care Board (ICB) introduced a new pathway that sets a minimum waiting period of two years for children and adults seeking assessments for attention deficit hyperactivity disorder (ADHD) and autism spectrum condition (ASC). The decision was presented as a response to rising demand and limited specialist capacity, but it immediately raised concerns among clinicians, families and advocacy groups.

Legal basis of the challenge

ADHD UK, the national charity representing people with ADHD, sent a formal legal letter to the ICB in May 2024. The letter argues that the policy breaches the National Health Service Act 2006 by imposing an unlawful delay on a service that is already recognised as a clinical priority. The charity says it will seek a judicial review if the board does not reverse the rule.

The legal claim rests on three main points:

1. Patients have a statutory right to timely assessment and treatment under NHS England standards.
2. The two-year minimum wait creates a blanket restriction that does not consider individual clinical urgency.
3. The policy may constitute indirect discrimination against people with neurodevelopmental conditions, contravening the Equality Act 2010.

Impact on families and patients

Waiting two years for an assessment can have profound effects on mental health, education and employment prospects. Parents report that delayed diagnosis often means prolonged periods of unmanaged symptoms, leading to school exclusions, strained family relationships and increased risk of comorbid conditions such as anxiety or depression.

Key consequences highlighted by families include:

• Loss of eligibility for educational support under the Children and Families Act 2014.
• Delayed access to medication or behavioural interventions that could improve daily functioning.
• Higher financial burden as families seek private assessments to bypass the public wait.

One parent told The Guardian that their child’s school performance had deteriorated sharply during the waiting period, and that the uncertainty was taking a toll on the whole household.

Responses from NHS and government

West Yorkshire ICB defended the policy as a pragmatic measure to manage a surge in referrals that, according to the board, increased by 35 per cent in the past year. A spokesperson said the ICB is investing in additional diagnostic slots and training for clinicians, but that a short‑term wait is unavoidable.

The Department of Health and Social Care has not issued a formal comment, but the NHS England website outlines national referral standards that aim for assessment within 18 weeks for most conditions. The discrepancy between the national target and the regional policy is a focal point of the legal argument.

Health Minister has previously emphasised the need for timely neurodevelopmental assessments, suggesting that the current situation may trigger a review of regional commissioning arrangements.

Potential outcomes and wider implications

If the judicial review succeeds, West Yorkshire ICB would be required to remove the minimum two‑year wait and align its pathway with national standards. Such a ruling could set a precedent for other ICBs that have introduced similar waiting periods.

Possible broader effects include:

• Increased scrutiny of ICB policies across England, especially where they affect vulnerable groups.
• Greater pressure on NHS England to allocate funding for diagnostic services.
• Enhanced advocacy for legislative clarification on the rights of people with ADHD and autism.

Conversely, a court decision upholding the policy might embolden other regions to adopt similar measures, potentially widening the gap in access to neurodevelopmental care.

What patients can do now

While the legal process unfolds, families can take several steps to mitigate the impact of long waits:

1. Contact local NHS trusts to request interim support, such as educational advice or medication reviews.
2. Explore publicly funded pilot programmes that offer faster assessments in certain areas.
3. Seek advice from patient advocacy groups like ADHD UK for guidance on navigating the referral system.
4. Consider applying for a private assessment if finances allow, keeping in mind that some private results can be shared with NHS clinicians.
5. Document symptoms and functional impact thoroughly to strengthen the case for urgent assessment if a clinician deems it necessary.

Ultimately, the legal challenge underscores the tension between limited resources and the statutory duty to provide timely care. The outcome will likely influence how the NHS balances demand with capacity for neurodevelopmental services in the years ahead.